Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, immune-related adverse events (irAEs) in the gastrointestinal (GI) system commonly occur. In this study, data were obtained from the US Food and Drug Administration adverse event reporting system between July 2014 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xiaoyin, Jiang, Shiyu, Zhou, Yangzhong, Zhen, Hongnan, Ji, Junyi, Li, Yi, Ruan, Gechong, Yang, Yang, Shen, Kaini, Wang, Luo, Li, Guanqiao, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667785/
https://www.ncbi.nlm.nih.gov/pubmed/34912213
http://dx.doi.org/10.3389/fphar.2021.720776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667785/
https://www.ncbi.nlm.nih.gov/pubmed/34912213
http://dx.doi.org/10.3389/fphar.2021.720776

Ejemplares similares